Pricing Log in Create free account

Dianthus Therapeutics, Inc. (DNTH) vs Edgewise Therapeutics, Inc. (EWTX)

Dianthus Therapeutics, Inc. and Edgewise Therapeutics, Inc. are both Biotechnology companies. Dianthus Therapeutics, Inc. and Edgewise Therapeutics, Inc. are of similar size ($4.2B and $4.2B). Edgewise Therapeutics, Inc. has the higher net margin (0.00% vs −10,097.0%) and the higher return on invested capital (0.00% vs −47.7%). Across the 13 metrics below, Dianthus Therapeutics, Inc. leads on 7 and Edgewise Therapeutics, Inc. on 6.

Valuation

Metric DNTH EWTX Biotechnology median
P/E n/m n/m 8.50
P/S 2,121.40 n/m 9.71
P/B 3.45 8.94 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1,655.63 n/m 9.21
Earnings yield (5.76%) (4.97%) (33.15%)
Free cash flow yield (3.86%) (3.97%) (25.50%)

Profitability

Metric DNTH EWTX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (11,441.39%) 0.00% 0.00%
Net margin (10,096.95%) 0.00% 0.00%
Free cash flow margin (8,177.99%) 0.00% 0.00%
Return on equity (26.07%) (38.03%) (56.36%)
Return on assets (24.98%) (36.09%) (48.04%)
Return on invested capital (47.74%) 0.00% 0.00%

Growth

Metric DNTH EWTX Biotechnology median
Revenue growth (TTM) (60.77%) — 6.02%
EPS growth (last fiscal year) (64.71%) (12.41%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DNTH EWTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 26.10 16.24 4.72
Net debt to EBITDA 2.20 2.69 0.96

Dividend

Metric DNTH EWTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DNTH EWTX Biotechnology median
Market cap 4.17b 4.15b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack